R
Royalty Pharma plc (RPRX)
NMS – Real Time Price. Currency in USD
56.23
+1.54 (2.82%)
At close: Jun 26, 2026, 4:00 PM EDT
56.01
-0.22 (-0.39%)
After-hours: Jun 26, 2026, 7:57 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
56.23
+1.54 (2.82%)
At close: Jun 26, 2026, 4:00 PM EDT
56.01
-0.22 (-0.39%)
After-hours: Jun 26, 2026, 7:57 PM EDT
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company has research and development funding collaboration to advance the development of JNJ-4804, an investigational medicine for autoimmune diseases. The company was founded in 1996 and is based in New York, New York.
| Name | Position |
|---|---|
| Dr. James Folmar Reddoch Ph.D. | Executive VP of Investments & Chief Scientific Officer |
| Dr. Marshall Jonathan Urist M.D., Ph.D. | Executive Vice President of Research & Investments |
| Mr. Arthur Richard McGivern J.D. | Executive VP of Investment & Chief Legal Officer |
| Mr. Christopher Hite | Chairman of Partnering & Investments |
| Mr. Eric Cornelius Schneider | Senior VP & Chief Technology Officer |
| Mr. George Grofik C.F.A., CPA | Senior VP and Head of Investor Relations & Communications |
| Mr. Pablo Legorreta | Founder, Chairman of the Board & CEO |
| Mr. Sandy Balkin Ph.D. | Senior Vice President of Strategy & Analytics |
| Mr. Terrance P. Coyne | Executive VP & CFO |
| Ms. Molly Sawaya | Executive VP & Head of Human Capital |
| Date | Type | Document |
|---|---|---|
| 2026-06-04 | 8-K | d855771d8k.htm |
| 2026-05-28 | 8-K | d131735d8k.htm |
| 2026-05-06 | 8-K | rprx-20260506.htm |
| 2026-05-06 | 10-Q | rprx-20260331.htm |
| 2026-04-13 | 8-K | d871473d8k.htm |
| 2026-04-10 | DEFA14A | ny20066979x2_defa14a.htm |
| 2026-04-10 | DEF 14A | ny20066979x1_def14a.htm |
| 2026-04-10 | ARS | ny20066979x3_ars.pdf |
| 2026-02-11 | 8-K | rprx-20260211.htm |
| 2026-02-11 | 10-K | rprx-20251231.htm |